• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

High-Versus Low-dose Angiotensin Converting Enzyme Inhibitor Therapy in the Treatment of Heart Failure: An Economic Analysis of the Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial

Publication
Article
The American Journal of Managed CareJune 2003
Volume 9
Issue 6

Related Videos
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.